BTI
ANAB icon

Blue Trust Inc’s AnaptysBio ANAB Stock Holding History

Blue Trust Inc’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Hold
19
– – ﹤0.01% 2258
2026
Q1 		$1.05K Hold
19
– – ﹤0.01% 2250
2025
Q4 		$921 Hold
19
– – ﹤0.01% 2301
2025
Q3 		$582 Hold
19
– – ﹤0.01% 2401
2025
Q2 		$422 Hold
19
– – ﹤0.01% 2331
2025
Q1 		$353 Buy
+19
New +$317 ﹤0.01% 2390
2023
Q2 		– Sell
-19
Closed -$1K – 2009
2023
Q1 		$1K Hold
19
– – ﹤0.01% 2095
2022
Q4 		$0 Hold
19
– – ﹤0.01% 2210
2022
Q3 		$0 Hold
19
– – ﹤0.01% 2071
2022
Q2 		$0 Buy
+19
New +$421 ﹤0.01% 1883

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Blue Trust Inc's ANAB Position: Q2 2026 in Review

Blue Trust Inc held its AnaptysBio (ANAB) position steady in Q2 2026 at 19 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

Blue Trust Inc first reported a position in ANAB in Q2 2022 and has held it in 10 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Blue Trust Inc held 19 shares of AnaptysBio worth $1.28K as of Q2 2026.
  • Blue Trust Inc left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2258 holding.
  • Blue Trust Inc first reported a position in AnaptysBio in Q2 2022 and has held it in 10 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.